Table 1.
Baseline Biochemical Parameters (Mean ± SD) and Prognostic Markers in All the Cases at the Time of Enrollment, and in Survived and Expired Cases.
| Biochemical parameters and prognostic markers | Total cases (N = 123) | Nonsurvivors (N = 62) | Survivors (N = 25) | ‘P’ value (Compared between survivors and nonsurvivors) |
|---|---|---|---|---|
| TLC/cmma | 9050 (3800–32,000) | 9000 (4000–32,000) | 10,000 (5000–20,000) | 0.57 |
| Urea (mg/dl)a | 28 (5.1–223) | 28.5 (5.1–152) | 43 (17–119) | 0.16 |
| Creatinine (mg/dl)a | 1.1 (0.5–8.1) | 1.03 (0.5–5.4) | 1.2 (0.6–8.1) | 0.07 |
| Sodium (mmol/L) | 131.82 ± 6.55 | 131.05 ± 6.86 | 131.92 ± 7.47 | 0.6 |
| Total bilirubin (mg/dl)a | 8.7 (5.1–40) | 9.4 (5.1–40) | 7.4 (5.1–19.2) | 0.21 |
| AST (IU/L)a | 98 (23–559) | 98 (23–509) | 97 (27–599) | 0.63 |
| ALT (IU/L)a | 64 (20–370) | 63 (20–370) | 62 (29–219) | 0.89 |
| ALP (IU/L)a | 260 (61–975) | 242 (61–975) | 312 (107–493) | 0.08 |
| Albumin (g/dl) | 2.74 ± 0.56 | 2.75 ± 0.6 | 2.78 ± 0.46 | 0.83 |
| INR (PT) | 2.46 ± 0.8 | 2.53 ± 0.81 | 2.49 ± 0.97 | 0.83 |
| CTP | 12.26 ± 1.27 | 12.24 ± 1.69 | 12.29 ± 1.18 | 0.87 |
| MELD | 27.47 ± 6.53 | 27.68 ± 6.16 | 27.76 ± 5.47 | 0.95 |
| MELD-Na | 29.74 ± 5.6 | 29.72 ± 5.21 | 30.19 ± 4.8 | 0.68 |
N: Number; TLC: total leukocyte count; AST: aspartate transaminase; ALT: alanine transaminase; ALP: alkaline phosphatase; INR (PT): International Normalized Ratio (Prothrombin Time); CTP: Child Turcotte Pugh; MELD: Model for End-Stage Liver Disease; MELD-Na: Model for End-Stage Liver Disease Sodium.
a
Median (range) value.